Moving from Vials to Prefilled Syringes: A Project Manager's Perspective.

In this article the author discusses the issue of moving an injectable therapeutic to prefilled-syringe format. He explores the benefits of the move which include meeting the demands of physicians and patients who look for easier administration, helping differentiate the product from competing drugs, and increasing sales of active pharmaceutical ingredient (API). He also explores the regulatory strategy in changing the presentation of the drug.